FDA orders vision-loss warning on GLP-1 drugs @ArirangCoKrArirangNEWS
FDA orders vision-loss warning on GLP-1 drugs  @ArirangCoKrArirangNEWS
Uploaded November 2026 | Updated November 2026, 16 hours ago
美 FDA, 비만치료제에 시력상실 위험 관련 경고문구 의무화

The U.S. Food and Drug Administration will require all GLP-1 drugs, including Wegovy and Zepbound, to carry a new safety warning about NAION, a rare condition that can cause sudden vision loss.
The FDA said on Monday the link has not been proven, but its review found a higher rate of the condition among patients taking the drugs. Cases of the rare condition have been reported for all GLP-1 products on the market.

#World_News #Food_and_Drug_Administration #GLP_1 #월드뉴스 #식품의약국 #비만치료제 #Arirang_News #아리랑뉴스

📣 Facebook : facebook.com/arirangtvnews
📣 Youtube : youtube.com/@ArirangCoKrArirangNEWS
📣 Homepage : v2.arirang.com

2026-11-11, 10:00 (KST)
FDA orders vision-loss warning on GLP-1 drugs[FULL] THE DAILY REPORT (2026-11-11)[FULL] NEW DAY at arirang (2026-11-12)BLACKPINKs Jennie reaches No.3 on the Billboard Hot 100 with song Dracula[Weather] Classic late-autumn temperature swing, sunnier skies in the afternoon[FULL] NEWSCENTER (2026-11-12)One week until APEC 2026, world leaders eye possible U.S.-China-Russia summit[K-Enter] Dead-End Job tops Netflixs non-English language TV rankings[Hallyu People] Bringing Korean sijo to the world[NEWs GEN] ONLY IN KOREA: The Incredible Moving Services That Surprise ForeignersNVIDIA CEO RESIGNSNVIDIA AI Day Seoul puts Koreas physical AI ambitions to the test
Arirang News |

FDA orders vision-loss warning on GLP-1 drugs

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER